| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.61 | 0.001 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |